References
- Udechuku A, Nguyen T, Hill R, Szego K. Antidepressants in pregnancy: a systematic review. Aust N Z J Psychiatry 2010; 44:978–996.
- Galbally M, Roberts M, Buist A, Perinatal Psychotropic Review Group. Mood stabilizers in pregnancy: a systematic review. Aust N Z J Psychiatry 2010; 44:967–977.
- McCauley-Elsom K, Gurvich C, Elsom SJ, Kulkarni J. Antipsychotics in pregnancy. J Psychiatr Ment Health Nurs 2010; 17:97–104.
- Newham JJ, Thomas SH, MacRitchie K . Birthweight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br J Psychiatry 2008; 11:249–250.
- Newport DJ, Calamaras MR, DeVane CL . Atypical antipsychotic administration during late pregnancy: placental passage and obstetric outcomes. Am J Psychiatry 2007; 164:1214–1220.
- Abilify Product Information. Bristol-Myers Squibb Pharmaceuticals. 2010. (cited 23 August 2010). Available from URL http://www.pbs.gov.au/pi/bqpabili10310.pdf
- Lutz UC, Hiemke C, Wiatr G . Aripiprazole in pregnancy and lactation: a case report. J Clin Psychopharmacol 2010; 30:204–205.
- Kulkarni J, Gilbert H, Gurvich C . The first 100 women in the National Register of Antipsychotic Medication in Pregnancy (NRAMP). Poster Presentation, Australian Schizophrenia Conference 22–24 September 2010, Sydney, Australia.
- Rummel-Cluge C, Komossa K, Schwarz S . Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res 2010; 123:255–233.